Health advisers from the National Institutes of Health, a federal division of the U.S. Department of Health and Human Services, criticized the U.S. Food and Drug Administration's recent assertion that convalescent plasma dramatically helps in treating patients suffering from Covid-19, according to a report from
Drug Administration participate in the daily coronavirus task force briefing at the White House on April 24, 2020 in Washington, DC. Earlier on Friday, President Trump signed into law the Paycheck Protection Program and Health Care Enhancement Act, a $484 billion bill that aids small businesses and hospitals under stress from the coronavirus pandemic.
The NIH panel shared in a statement that there was"no difference in 7-day survival overall" in patients that received plasma as a treatment, despite the Trump administration claiming survival rates rose by 35%, with the group further saying, “There are insufficient data to recommend either for or against the use of convalescent plasma for the treatment of COVID-19.”
MattRyanPerez I think that when we have a health crisis like this we should try every possible treatment...
MattRyanPerez I swear if it comes out of President Trumps mouth all the liberals and dems rush to contradict him in any and every way possible.🙄 It’s really tiresome now
MattRyanPerez COVID19 🇺🇸
MattRyanPerez It is crap like this that makes people not want the Covid vaccine when it’s available.
MattRyanPerez According to another report, Forbes sucks.
MattRyanPerez I'm shocked...
MattRyanPerez Oh Jesus Christ
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Forbes - 🏆 394. / 53 Read more »